02256.HK
Abbisko Cayman Limited
HKSE · Healthcare · Biotechnology · CN
HKD 8.77
−1.79%Leverage
- Debt / equity
- 0.21x
- Net debt / equity
- -0.19x
- Debt / assets
- 0.17x
- Debt / EBITDA
- -0.89x
- Net debt / EBITDA
- 0.82x
Liquidity & coverage
- Current ratio
- 4.82x
- Quick ratio
- 4.82x
- Cash ratio
- 4.78x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- HKD 2.3B
Cash & dividend
- FCF / debt
- -0.50x
- Cash flow / debt
- -0.49x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026